Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial

被引：77

作者：

Sanchez, Olivier ^{[1
,2
,3
,4
]}

Charles-Nelson, Anais ^{[5
,6
]}

Ageno, Walter ^{[7
]}

Barco, Stefano ^{[8
,9
]}

Binder, Harald ^{[10
,11
]}

Chatellier, Gilles ^{[3
,5
,6
]}

Duerschmied, Daniel ^{[12
]}

Empen, Klaus ^{[13
]}

Ferreira, Melanie ^{[14
]}

Girard, Philippe ^{[4
,15
]}

Huisman, Menno, V ^{[16
]}

Jimenez, David ^{[17
]}

Katsahian, Sandrine ^{[3
,5
,6
,18
]}

Kozak, Matija ^{[19
]}

Lankeit, Mareike ^{[8
,20
,21
]}

Meneveau, Nicolas ^{[4
,22
,23
]}

Pruszczyk, Piotr ^{[24
]}

Petris, Antoniu ^{[25
]}

Righini, Marc ^{[26
]}

Rosenkranz, Stephan ^{[27
,28
]}

Schellong, Sebastian ^{[29
]}

Stefanovic, Branislav ^{[30
]}

Verhamme, Peter ^{[31
]}

de Wit, Kerstin ^{[32
]}

Vicaut, Eric ^{[33
]}

Zirlik, Andreas ^{[34
]}

Konstantinides, Stavros, V ^{[8
,35
]}

Meyer, Guy ^{[1
,3
,4
]}

机构：

[1] Univ Paris, Hop Europeen Georges Pompidou, AP HP, AP HP Ctr,Serv Pneumol & Soins Intensifs, Paris, France

[2] INSERM UMR S 1140 Innovative Therapies Hemostasis, Paris, France

[3] Univ Paris, Paris, France

[4] FCRIN INNOVTE, St Etienne, France

[5] Hop Europeen Georges Pompidou, AP HP, AP HP Ctr, Unite Rech Clin, Paris, France

[6] Ctr Invest Clin 1418 CIC1418 Epidemiol Clin, INSERM, Paris, France

[7] Univ Insubria, Dept Med & Surg, Varese, Italy

[8] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis CTH, Mainz, Germany

[9] Univ Hosp Zurich, Clin Angiol, Zurich, Switzerland

[10] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany

[11] Univ Freiburg, Med Ctr, Freiburg, Germany

[12] Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Fac Med, Dept Cardiol & Angiol 1, Freiburg, Germany

[13] Stadt Klinikum Dessau, Dept Internal Med, Dessau, Germany

[14] Hosp Garcia Orta, Internal Med Dept, Almada, Portugal

[15] Inst Mutualiste Montsouris, Dept Thorac, Paris, France

[16] Leiden Univ Med Ctr, Dept Thrombosis & Hemostasis, Dutch Thrombosis Network, Leiden, Netherlands

[17] Univ Alcala IRYCIS, Ramon y Cajal Hosp, Dept Resp Dis, CIBER Enfermedades Resp CIBERES, Madrid, Spain

[18] Ctr Rech Cordeliers, INSERM UMR S 1138 Equipe 22, Paris, France

[19] Univ Med Ctr, Dept Vasc Dis, Ljubljana, Slovenia

[20] Vivantes Klinikum Friedrichshain, Dept Internal Med Vasc Med & Haemostaseol, Berlin, Germany

[21] Univ Med Ctr Goettingen, Clin Cardiol & Pneumol, Gottingen, Germany

[22] Univ Hosp Jean Minjoz, Dept Cardiol, Besancon, France

[23] Univ Burgundy Franche Comte, EA3920, Besancon, France

[24] Med Univ Warsaw, Dept Internal Med & Cardiol, Warsaw, Poland

[25] Grigore T Popa Univ Med & Pharm Iasi, Cardiol Clin, St Spiridon Cty Clin Emergency Hosp, Iasi, Romania

[26] Univ Geneva, Geneva Univ Hosp, Div Angiol & Haemostasis, Geneva, Switzerland

[27] Cologne Univ, Dept Internal Med 3, Heart Ctr, Cologne, Germany

[28] Cologne Univ, Cologne Cardiovasc Res Ctr CCRC, Heart Ctr, Cologne, Germany

[29] Municipal Hosp Dresden, Dept Internal Med 2, Dresden, Germany

[30] Univ Belgrade, Univ Clin Ctr Serbia, Emergency Ctr, Cardiol Clin,Sch Med, Belgrade, Serbia

[31] Univ Hosp Leuven, Dept Cardiovasc Med, Vasc Med & Haemostasis, Leuven, Belgium

[32] McMaster Univ, Dept Med, Hamilton, ON, Canada

[33] Univ Paris 07, AP HP, Unite Rech Clin St Louis Lariboisiere, Paris, France

[34] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria

[35] Democritus Univ Thrace, Dept Cardiol, Alexandroupolis, Greece

来源：

THROMBOSIS AND HAEMOSTASIS | 2022年 / 122卷 / 05期

基金：

加拿大健康研究院;

关键词：

pulmonary embolism; intermediate-high-risk; reduced-dose thrombolysis; prognosis; randomized trial; PLASMINOGEN-ACTIVATOR; RANDOMIZED-TRIAL; MULTICENTER TRIAL; EUROPEAN-SOCIETY; SINGLE-ARM; VALIDATION; ALTEPLASE; BOLUS; PROGNOSTICATION; STRATIFICATION;

D O I：

10.1055/a-1653-4699

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Intermediate-high-risk pulmonary embolism (PE) is characterized by right ventricular (RV) dysfunction and elevated circulating cardiac troponin levels despite apparent hemodynamic stability at presentation. In these patients, full-dose systemic thrombolysis reduced the risk of hemodynamic decompensation or death but increased the risk of life-threatening bleeding. Reduced-dose thrombolysis may be capable of improving safety while maintaining reperfusion efficacy. The Pulmonary Embolism International THrOmbolysis (PEITHO)-3 study (ClinicalTrials.gov Identifier: NCT04430569) is a randomized, placebo-controlled, double-blind, multicenter, multinational trial with long-term follow-up. We will compare the efficacy and safety of a reduced-dose alteplase regimen with standard heparin anticoagulation. Patients with intermediate-high-risk PE will also fulfill at least one clinical criterion of severity: systolic blood pressure <= 110mm Hg, respiratory rate >20 breaths/min, or history of heart failure. The primary efficacy outcome is the composite of all-cause death, hemodynamic decompensation, or PE recurrence within 30 days of randomization. Key secondary outcomes, to be included in hierarchical analysis, are fatal or GUSTO severe or life-threatening bleeding; net clinical benefit (primary efficacy outcome plus severe or life-threatening bleeding); and all-cause death, all within 30 days. All outcomes will be adjudicated by an independent committee. Further outcomes include PE-related death, hemodynamic decompensation, or stroke within 30 days; dyspnea, functional limitation, or RV dysfunction at 6 months and 2 years; and utilization of health care resources within 30 days and 2 years. The study is planned to enroll 650 patients. The results are expected to have a major impact on risk-adjusted treatment of acute PE and inform guideline recommendations.

引用

页码：857 / 866

页数：10

共 40 条

[31] Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: A meta-analysis [J].

Riera-Mestre, Antoni ;

Becattini, Cecilia ;

Giustozzi, Michela ;

Agnelli, Giancarlo .

THROMBOSIS RESEARCH, 2014, 134 (06) :1265-1271

[32] Prognostic Factors for Pulmonary Embolism The PREP Study, A Prospective Multicenter Cohort Study [J].

Sanchez, Olivier ;

Trinquart, Ludovic ;

Caille, Vincent ;

Couturaud, Francis ;

Pacouret, Gerard ;

Meneveau, Nicolas ;

Verschuren, Franck ;

Roy, Pierre-Marie ;

Parent, Florence ;

Righini, Marc ;

Perrier, Arnaud ;

Lorut, Christine ;

Tardy, Bernard ;

Benoit, Marie-Odile ;

Chatellier, Gilles ;

Meyer, Guy .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (02) :168-173

[33] Moderate Pulmonary Embolism Treated With Thrombolysis (from the "MOPETT" Trial) [J].

Sharifi, Mohsen ;

Bay, Curt ;

Skrocki, Laura ;

Rahimi, Farnoosh ;

Mehdipour, Mahshid .

AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (02) :273-277

[34] HEMODYNAMIC-EFFECTS OF BOLUS VS 2-H INFUSION OF ALTEPLASE IN ACUTE MASSIVE PULMONARY-EMBOLISM - A RANDOMIZED CONTROLLED MULTICENTER TRIAL [J].

SORS, H ;

PACOURET, G ;

AZARIAN, R ;

MEYER, G ;

CHARBONNIER, B ;

SIMONNEAU, G .

CHEST, 1994, 106 (03) :712-717

[35] A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism The OPTALYSE PE Trial [J].

Tapson, Victor F. ;

Sterling, Keith ;

Jones, Noah ;

Elder, Mahir ;

Tripathy, Uttam ;

Brower, Jayson ;

Maholic, Robert L. ;

Ross, Charles B. ;

Natarajan, Kannan ;

Fong, Pete ;

Greenspon, Lee ;

Tamaddon, Houman ;

Piracha, Amir R. ;

Engelhardt, Tod ;

Katopodis, John ;

Marques, Vasco ;

Sharp, Andrew S. P. ;

Piazza, Gregory ;

Goldhaber, Samuel Z. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (14) :1401-1410

[36] AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION [J].

TOPOL, E ;

CALIFF, R ;

VANDEWERF, F ;

ARMSTRONG, PW ;

AYLWARD, P ;

BARBASH, G ;

BATES, E ;

BETRIU, A ;

BOISSEL, JP ;

CHESEBRO, J ;

COL, J ;

DEBONO, D ;

GORE, J ;

GUERCI, A ;

HAMPTON, J ;

HIRSH, J ;

HOLMES, D ;

HORGAN, J ;

KLEIMAN, N ;

MARDER, V ;

MORRIS, D ;

OHMAN, M ;

PFISTERER, M ;

ROSS, A ;

RUTSCH, W ;

SADOWSKI, Z ;

SIMOONS, M ;

VAHANIAN, A ;

WEAVER, WD ;

WHITE, H ;

WILCOX, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (10) :673-682

[37] A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism The FLARE Study [J].

Tu, Thomas ;

Toma, Catalin ;

Tapson, Victor F. ;

Adams, Christopher ;

Label, Wissam A. ;

Silver, Mitchell ;

Khandhar, Sameer ;

Amin, Rohit ;

Weinberg, Mitchell ;

Engelhardt, Tod ;

Hunter, Monica ;

Holmes, David ;

Hoots, Glenn ;

Hamdalla, Hussam ;

Maholic, Robert L. ;

Lilly, Scott M. ;

Ouriel, Kenneth ;

Rosenfield, Kenneth .

JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (09) :859-869

[38] Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism A Randomized, Multicenter, Controlled Trial [J].

Wang, Chen ;

Zhai, Zhenguo ;

Yang, Yuanhua ;

Wu, Qi ;

Cheng, Zhaozhong ;

Liang, Lirong ;

Dai, Huaping ;

Huang, Kewu ;

Lu, Weixuan ;

Zhang, Zhonghe ;

Cheng, Xiansheng ;

Shen, Ying H. .

CHEST, 2010, 137 (02) :254-262

[39] Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: A systematic review and meta-analysis [J].

Zhang, Zhu ;

Zhai, Zhen-guo ;

Liang, Li-rong ;

Liu, Fang-fang ;

Yang, Yuan-hua ;

Wang, Chen .

THROMBOSIS RESEARCH, 2014, 133 (03) :357-363

[40] Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study [J].

Zondag, W. ;

Mos, I. C. M. ;

Creemers-Schild, D. ;

Hoogerbrugge, A. D. M. ;

Dekkers, O. M. ;

Dolsma, J. ;

Eijsvogel, M. ;

Faber, L. M. ;

Hofstee, H. M. A. ;

Hovens, M. M. C. ;

Jonkers, G. J. P. M. ;

Van Kralingen, K. W. ;

Kruip, M. J. H. A. ;

Vlasveld, T. ;

De Vreede, M. J. M. ;

Huisman, M. V. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (08) :1500-1507

← 1 2 3 4 →